OP 6.4 – 00096 High-efficiency CRISPR/Cas9-mediated disruption of ccr5 in human hematopoietic stem progenitor cells generates HIV-refractory immune systems
D. Claiborne,
Z. Detwiler,
K. Okawa,
T. Bateson,
T. Chen,
D. Scadden,
C. Boutwell,
T. Allen
Affiliations
D. Claiborne
Wistar Institute, Philadelphia, PA, USA
Z. Detwiler
CRISPR Therapeutics, Cambridge, MA, USA
K. Okawa
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
T. Bateson
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
T. Chen
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
D. Scadden
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA
C. Boutwell
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
T. Allen
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
